CASI Pharmaceuticals, Inc. (CASI)
0.801
-0.06
(-6.52%)
USD |
NASDAQ |
Dec 10, 09:33
CASI Pharmaceuticals Shareholders Equity (Quarterly): -25.73M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sinovac Biotech Ltd. | -- |
| China Pharma Holdings, Inc. | 8.494M |
| Zai Lab Ltd. | 759.94M |
| Adagene, Inc. | -- |
| Adlai Nortye Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.33M |
| Total Liabilities (Quarterly) | 53.05M |
| Debt to Equity Ratio | -0.7329 |
| Current Ratio | 0.3023 |
| Net Debt Paydown Yield | -0.23% |